The IMID Forum
The Immune-Mediated Inflammatory Disease Forum
Keeping you up to date with the latest and most important updates in immune-mediated inflammatory diseases.
Episodes
Mentioned books
Dec 29, 2020 • 22min
Rheumatology Author Dr Kerschbaumer: JAKinibs
Dr Andreas Kerschbaumer from Vienna University. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Andreas Kerschbaumer discusses his systematic review paper on “Points to Consider for the Treatment of Immune Mediated Inflammatory Diseases with Janus Kinase Inhibitors
Dec 22, 2020 • 21min
Rheumatology Author Prof Kevin Winthrop: Tofacitinib
Prof Kevin Winthrop from OHSU. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Kevin Winthrop discusses aged based incidence of infections with tofacitinib
Dec 22, 2020 • 20min
Discussing Rheumatology: JAK Inhibitors
Prof Iain McInnes discusses JAK inhibitors. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
Dec 9, 2020 • 22min
Perspectives in Inflammation - Professor Emery
Past President of EULAR and Carol Nachman Prize winner. In this podcast, Professor Paul Emery discusses his work in managing early RA and the growth of his unit at Leeds into a world leading centre for rheumatology research alongside Professor Michael Weinblatt. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.
Nov 30, 2020 • 11min
Insights at ACR 2020: Highlights from ACR 2020
Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes a preview of an upcoming Highlights from ACR 2020 course from Professors Kevin Winthrop and Leonard Calabrese, available soon on the CSF website.
Nov 25, 2020 • 22min
Rheumatology Author Prof Stanley Cohen: Upadacitinib
Prof Stanley Cohen - University of Texas. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Stanley Cohen discusses safety profile of upadacitinib
Nov 25, 2020 • 7min
Discussing Rheumatology: Upadacitinib Safety
Prof Iain McInnes discusses upadacitinib safety. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com
Nov 23, 2020 • 32min
Insights at ACR 2020: Efficacy And Safety Of JAK Inhibitors
Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great efficacy and safety data on JAK inhibitors from Professors Kevin Winthrop, Stanely Cohen, Ernest Choy and Rene Westhovens.
Nov 23, 2020 • 26min
Insights at ACR 2020: New Developments in Cytokine Signalling
Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great new developments in cytokine signalling abstracts from Professors Iain McInnes, Xenfon Baraliakos and Maya Buch.
Nov 19, 2020 • 19min
Insights at ACR 2020: Bone And Patient Outcomes With RA
Gain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great bone and patient outcomes abstracts from Professors Rieke Alten, Vibeke Strand and Zoltan Szekanecz.
